Fornasari P M, Riva G, Piccolo G, Cosi V, Lombardi M
Int J Artif Organs. 1985 May;8(3):159-62.
The authors examine the results of plasma exchange (PE) treatment in 33 patients with myasthenia gravis, who underwent a total of 49 cycles of treatment. On the basis of clinical response, evaluated in relation to a modification of the functional state and to the duration of improvement after PE, we selected a group of 20 responsive patients ("responders" = 60.6%) and 13 non-responsive patients ("non-responders" = 39.4%). Positive effects, some only short-lasting, were observed in 24 patients (72.7%) after 32 cycles of a total of 49 cycles (65.3%). Out of the 11 most critical patients, 7 (63.6%) were considered responders, given the importance and duration of the improvement they presented, while 2 other patients had clear but short-lasting improvements; in these 9 patients, the positive effects amounted to 81.2%. Factors presumably responsible for therapeutic failure in the non-responders are discussed.
作者研究了33例重症肌无力患者接受血浆置换(PE)治疗的结果,这些患者总共接受了49个疗程的治疗。根据临床反应,通过评估功能状态的改善情况以及血浆置换后改善的持续时间,我们选出了一组20例有反应的患者(“反应者”=60.6%)和13例无反应的患者(“无反应者”=39.4%)。在总共49个疗程中的32个疗程后,24例患者(72.7%)出现了积极效果,其中一些效果只是短期的(占65.3%)。在11例最危急的患者中,7例(63.6%)被视为反应者,鉴于他们所呈现的改善的重要性和持续时间,另外2例患者有明显但短暂的改善;在这9例患者中,积极效果达81.2%。文中讨论了无反应者治疗失败可能的相关因素。